Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) SHZ
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Shenzhen Kangtai Biological Products Co., Ltd.
Address
Science and Technology Park
Shenzhen, 518057
China
Phone
86 755 2698 8658
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1913
First IPO Date
February 08, 2017
Key Executives
| Name | Title | Pay | Year Born |
| Cui Dong Huang | Accounting Supervisor & Head of Accounting Department | 0 | N/A |
| Jianhui Gan | Vice President | 0 | 1969 |
| Qi Nie Xiao | Vice President | 0 | 1983 |
| Jiankai Liu | Vice President & Non-Independent Director | 0 | 1970 |
| Jianying Ma | Chief Financial Officer | 0 | 1979 |
| Xiang Miao | President & Non-Independent Director | 0 | 1973 |
| Jin Tao | Vice President & Board Secretary | 0 | 1983 |
Description
Established in 1992 and headquartered in Shenzhen, China, Shenzhen Kangtai Biological Products Co., Ltd. is dedicated to the research, development, manufacturing, and commercialization of a diverse array of human vaccines across the Chinese market. The company's extensive portfolio includes essential immunizations such as the SARS-COV-2 vaccine, recombinant hepatitis B vaccine, and various pneumococcal disease vaccines (including 13-valent conjugate and 23-valent polysaccharide types). Its offerings also encompass combined vaccines like diphtheria, tetanus, acellular pertussis, and haemophilus influenzae type b, in addition to specific haemophilus influenzae type b conjugate, measles and rubella live attenuated, rabies, and inactivated poliomyelitis vaccines. Internationally, the company has partnered with YTB and Yong Tai Berhad to develop and commercialize a Covid-19 inactivated vaccine specifically for Malaysia.
